Escitalopram (sold as Lexapro) is an SSRI antidepressant used for major depressive disorder and generalized anxiety disorder.
SSRIs work by blocking the serotonin transporter (SERT), which keeps more serotonin available between nerve cells. That extra serotonin signaling is the basis for the drug's effect on mood and anxiety, though the full picture of why SSRIs help is still being worked out.
The main gene for escitalopram metabolism is CYP2C19, a liver enzyme that handles a large share of common medications.
CYP2C19 variants either speed the enzyme up or slow it down. Poor metabolizers clear escitalopram slowly, so concentrations climb and side effects come along with it. Ultrarapid metabolizers clear it too fast, and standard doses may never reach therapeutic levels.
Your CYP2C19 phenotype (ultrarapid, rapid, normal, intermediate, or poor) sets how quickly your body clears escitalopram, which in turn drives whether you reach therapeutic levels and how many side effects you'll have at a given dose.
The following dosing guidelines are based on the CPIC recommendations for escitalopram and CYP2C19 genotype.
| Phenotype | Clinical Consequence | Guideline Recommendation |
|---|---|---|
| Ultrarapid Metabolizer | You may break down the drug too quickly, making it less effective. | Consider a clinically appropriate alternative antidepressant not predominantly metabolized by CYP2C19. If escitalopram is clinically appropriate and efficacy is not achieved at standard maintenance dosing, consider titrating to a higher maintenance dose. |
| Rapid Metabolizer | You may process the drug faster, reducing its effects. | Initiate therapy with recommended starting dose. If patient does not adequately respond, consider increasing the maintenance dose or switching to an alternative antidepressant not predominantly metabolized by CYP2C19. |
| Normal Metabolizer | Standard dosing is expected to work for you. | Initiate therapy with recommended starting dose. |
| Intermediate Metabolizer | Your body may break down the drug more slowly, increasing side effects. | Initiate therapy with recommended starting dose. Consider a slower titration schedule and lower maintenance dose than normal metabolizers. |
| Likely Intermediate Metabolizer | Your body may break down the drug more slowly, so you might need a lower or slower-adjusted dose. | Initiate therapy with recommended starting dose. Consider a slower titration schedule and lower maintenance dose than normal metabolizers. |
| Likely Poor Metabolizer | You process the drug very slowly, which may raise side effects. | Consider a clinically appropriate antidepressant not predominantly metabolized by CYP2C19. If escitalopram is clinically appropriate, consider a lower starting dose, slower titration schedule, and 50% reduction of the standard maintenance dose compared with normal metabolizers. |
| Poor Metabolizer | You break down the drug very slowly, increasing risk of side effects. | Consider a clinically appropriate antidepressant not predominantly metabolized by CYP2C19. If escitalopram is clinically appropriate, consider a lower starting dose, slower titration schedule, and 50% reduction of the standard maintenance dose compared with normal metabolizers. |
| Indeterminate | The impact of your genotype on response to this drug is unknown. | Initiate therapy with recommended starting dose. |
| Not available | The impact of your genotype on response to this drug is unknown. | Initiate therapy with recommended starting dose. |
Examples of alternative treatment options from CPIC guidelines include selecting an antidepressant not predominantly metabolized by CYP2C19—such as sertraline, mirtazapine, or bupropion—depending on clinical judgment. These are provided as examples and not direct medical advice.
Gene2Rx uses the same CPIC and FDA guidelines as GeneSight, covers more medications, costs $5-$49 instead of several hundred, and works with the 23andMe or AncestryDNA data you may already have. See the full side-by-side comparison before ordering.
See the full list of drugs affected by each gene:
See how your genetics affect each product Escitalopram shows up in:
Learn more about how genetics may affect your response to Escitalopram and related medications:
Interested in learning more about how your genetics may affect your response to medication? Get started with Gene2Rx today.
I'm Interested